Dublin, June 20, 2022 (GLOBE NEWSWIRE) -- The "Psoriasis Therapeutics Market: Global Industry Analysis, Trends, Market Size, and Forecasts up to 2028" report has been added to ResearchAndMarkets.com's offering.
The report on the global psoriasis therapeutics market provides qualitative and quantitative analysis for the period from 2020 to 2028.
The report predicts the global psoriasis therapeutics market to grow with a CAGR of 9% over the forecast period from 2022-2028. The study on psoriasis therapeutics market covers the analysis of the leading geographies such as North America, Europe, Asia-Pacific, and RoW for the period of 2020 to 2028.
The report on psoriasis therapeutics market is a comprehensive study and presentation of drivers, restraints, opportunities, demand factors, market size, forecasts, and trends in the global psoriasis therapeutics market over the period of 2020 to 2028. Moreover, the report is a collective presentation of primary and secondary research findings.
Porter's five forces model in the report provides insights into the competitive rivalry, supplier and buyer positions in the market and opportunities for the new entrants in the global psoriasis therapeutics market over the period of 2020 to 2028. Further, Growth Matrix gave in the report brings an insight into the investment areas that existing or new market players can consider.
Report Findings
1) Drivers
- Rising incidence of psoriasis with skin disorders
- Increasing awareness among people
2) Restraints
- High costs of therapies
3) Opportunities
- Cumulative development of new biologics and new pipeline drugs
What does this Report Deliver?
1. Comprehensive analysis of the global as well as regional markets of the psoriasis therapeutics market.
2. Complete coverage of all the segments in the psoriasis therapeutics market to analyze the trends, developments in the global market and forecast of market size up to 2028.
3. Comprehensive analysis of the companies operating in the global psoriasis therapeutics market. The company profile includes analysis of product portfolio, revenue, SWOT analysis and latest developments of the company.
4. Growth Matrix presents an analysis of the product segments and geographies that market players should focus to invest, consolidate, expand and/or diversify.
Key Topics Covered:
1. Preface
1.1. Report Description
1.2. Research Methods
1.3. Research Approaches
2. Executive Summary
2.1. Psoriasis Therapeutics Market Highlights
2.2. Psoriasis Therapeutics Market Projection
2.3. Psoriasis Therapeutics Market Regional Highlights
3. Global Psoriasis Therapeutics Market Overview
3.1. Introduction
3.2. Market Dynamics
3.2.1. Drivers
3.2.2. Restraints
3.2.3. Opportunities
3.3. Analysis of COVID-19 impact on the Psoriasis Therapeutics Market
3.4. Porter's Five Forces Analysis
3.5. Growth Matrix Analysis
3.5.1. Growth Matrix Analysis by Molecule Type
3.5.2. Growth Matrix Analysis by Route of Administration
3.5.3. Growth Matrix Analysis by Dosage
3.5.4. Growth Matrix Analysis by Region
3.6. Value Chain Analysis of Psoriasis Therapeutics Market
4. Psoriasis Therapeutics Market Macro Indicator Analysis
5. Global Psoriasis Therapeutics Market by Molecule Type
5.1. Biologics
5.2. Small Molecules
6. Global Psoriasis Therapeutics Market by Route of Administration
6.1. Oral
6.2. Parenteral
6.3. Topical
7. Global Psoriasis Therapeutics Market by Dosage
7.1. TNF Inhibitors
7.2. PDE4 Inhibitors
7.3. Interleukin Blockers
7.4. Others
8. Global Psoriasis Therapeutics Market by Region 2022-2028
8.1. North America
8.1.1. North America Psoriasis Therapeutics Market by Molecule Type
8.1.2. North America Psoriasis Therapeutics Market by Route of Administration
8.1.3. North America Psoriasis Therapeutics Market by Dosage
8.1.4. North America Psoriasis Therapeutics Market by Country
8.2. Europe
8.2.1. Europe Psoriasis Therapeutics Market by Molecule Type
8.2.2. Europe Psoriasis Therapeutics Market by Route of Administration
8.2.3. Europe Psoriasis Therapeutics Market by Dosage
8.2.4. Europe Psoriasis Therapeutics Market by Country
8.3. Asia-Pacific
8.3.1. Asia-Pacific Psoriasis Therapeutics Market by Molecule Type
8.3.2. Asia-Pacific Psoriasis Therapeutics Market by Route of Administration
8.3.3. Asia-Pacific Psoriasis Therapeutics Market by Dosage
8.3.4. Asia-Pacific Psoriasis Therapeutics Market by Country
8.4. RoW
8.4.1. RoW Psoriasis Therapeutics Market by Molecule Type
8.4.2. RoW Psoriasis Therapeutics Market by Route of Administration
8.4.3. RoW Psoriasis Therapeutics Market by Dosage
8.4.4. RoW Psoriasis Therapeutics Market by Sub-region
9. Company Profiles and Competitive Landscape
9.1. Competitive Landscape in the Global Psoriasis Therapeutics Market
9.2. Companies Profiled
9.2.1. Astellas Pharma Inc.
9.2.2. AstraZeneca plc
9.2.3. Boehringer Ingelheim GmbH
9.2.4. F. Hofffmann-La Roche
9.2.5. GlaxoSmithKline plc
9.2.6. Merck and Co., Inc.
9.2.7. Valeant Pharmaceuticals International, Inc.
9.2.8. Biocon Limited
9.2.9. Eli Lilly and Company
9.2.10. G and W Laboratories Inc.
For more information about this report visit https://www.researchandmarkets.com/r/bwm35n
